from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0254c/cobU

LFCtreatmentdescriptionclass of inhibitor

0.045

Amikacinug/mL Amikacintranslation

-0.129

Cap5-10ug/mL Capreomycintranslation

-0.106

Rox10-50 ug/mL Roxithromycintranslation

-0.379

SM2-5 ug/mL Streptomycintranslation

-0.430

Tet5-10 ug/mL Tetracyclinetranslation

1.447

Rif0.2-5ug/mL Rifampicintranscription

0.928

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.888

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.926

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.144

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.290

Clofazimine10-13 ug/mL Clofaziminerespiration

0.346

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.725

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.786

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.170

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

2.115

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.019

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.937

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.819

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.516

KCN5-20 ug/mL Potassium cyaniderespiration

0.998

NaN30.2-2 mM Sodium aziderespiration

0.212

Nigericin50 uM Nigericinrespiration

0.754

TRC10-150 ug/mL Triclosanrespiration

1.098

TRZ10-25 ug/mL Thioridazinerespiration

-0.508

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.597

menadione6-10 ug/mL Menadionerespiration

-0.323

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.676

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.277

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.615

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.261

NRP_1Non-replicating persistence stage 1dosRassociated

-0.683

Amp0.2mg/mL AmpicillincellWall

-0.474

Cephalexin20-100 ug/mL CephalexincellWall

-0.645

Cerulenin0.32-5 ug/mL CerulenincellWall

0.905

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.688

EMB10-20 ug/mL EthambutolcellWall

-0.810

Eta12-40 ug/mL EthionamidecellWall

-0.728

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.173

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.684

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.224

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.312

BZA0.12 mg/mL BenzamidearomaticAmides

0.145

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.394

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.182

H2O24 mM hydrogen peroxideDNAdamaging

-0.028

Levo10 ug/mL LevofloxacinDNAdamaging

-0.689

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.892

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.155

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.915

UVUV-irradiationDNAdamaging

-0.712

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.616

Antimycin12.5-50 ug/mL Antimycin A?

0.156

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.262

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.882

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.035

PA8240.2-2 ug/mL PA-824?

-0.345

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.370

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.163

Verapamil50 uM Verapamil?

0.026

mercaptoethanol2 mM 2-Mercaptoethanol?

0.807

methoxatin10-20 ug/mL Methoxatin?